Idioma:

Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles

Nagai, Noriaki ; Ogata, Fumihiko ; Otake, Hiroko ; Nakazawa, Yosuke ; Kawasaki, Naohito

International journal of nanomedicine, 2019-01, Vol.14, p.1213-1227 [Periódico revisado por pares]

New Zealand: Dove Medical Press Limited

Texto completo disponível

Citações Citado por

Enviar para

Título:
Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles
Autor: Nagai, Noriaki ; Ogata, Fumihiko ; Otake, Hiroko ; Nakazawa, Yosuke ; Kawasaki, Naohito
Assuntos: Albinism ; Analysis ; Animals ; Bioavailability ; Biological Availability ; Cell Line ; Clathrin ; Cold ; Cold Temperature ; Cornea - drug effects ; Design ; drug delivery system ; Drug delivery systems ; Drugs ; endocytosis ; Endocytosis - drug effects ; Epithelial Cells - drug effects ; Epithelial Cells - metabolism ; Epithelium, Corneal - cytology ; Indomethacin ; Indomethacin - administration & dosage ; Indomethacin - pharmacokinetics ; Indomethacin - pharmacology ; Inflammation ; Instillation, Drug ; Laboratory animals ; nanomedicine ; Nanoparticles ; Nanoparticles - chemistry ; ophthalmic formulation ; Original Research ; Particle Size ; Permeability ; Pharmacy ; Rabbits ; Solubility ; T cells ; Vehicles
É parte de: International journal of nanomedicine, 2019-01, Vol.14, p.1213-1227
Descrição: We previously found that ophthalmic formulations containing nanoparticles prepared by a bead mill method lead to an increase in bioavailability in comparison with traditional formulations (solution type). However, the transcorneal penetration pathway for ophthalmic formulations has not been explained yet. In this study, we investigated the mechanism of transcorneal penetration in the application of ophthalmic formulations containing indomethacin nanoparticles (IMC-NPs). IMC-NPs was prepared by the bead mill method. For the analysis of energy-dependent endocytosis, corneal epithelial (HCE-T) cell monolayers and removed rabbit cornea were thermoregulated at 4°C, where energy-dependent endocytosis is inhibited. In addition, for the analysis of different endocytosis pathways using pharmacological inhibitors, inhibitors of caveolae-mediated endocytosis (54 µM nystatin), clathrin-mediated endocytosis (40 µM dynasore), macropinocytosis (2 µM rottlerin) or phagocytosis (10 µM cytochalasin D) were used. The ophthalmic formulations containing 35-200 nm sized indomethacin nanoparticles were prepared by treatment with a bead mill, and no aggregation or degradation of indomethacin was observed in IMC-NPs. The transcorneal penetration of indomethacin was significantly decreased by the combination of nystatin, dynasore and rottlerin, and the decreased penetration levels were similar to those at 4°C in HCE-T cell monolayers and rabbit cornea. In the in vivo experiments using rabbits, dynasore and rottlerin tended to decrease the transcorneal penetration of indomethacin (area under the drug concentration - time curve in the aqueous humor [AUC ]), and the AUC in the nystatin-treated rabbit was significantly lower than that in non-treatment group. In addition, the AUC in rabbit corneas undergoing multi-treatment was obviously lower than that in rabbit corneas treated with each individual endocytosis inhibitor. We found that three energy-dependent endocytosis pathways (clathrin-dependent endocytosis, caveolae-dependent endocytosis and macropinocytosis) are related to the trans-corneal penetration of indomethacin nanoparticles. In particular, the caveolae-dependent endocytosis is strongly involved.
Editor: New Zealand: Dove Medical Press Limited
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles

Nagai, Noriaki ; Ogata, Fumihiko ; Otake, Hiroko ; Nakazawa, Yosuke ; Kawasaki, Naohito

New Zealand: Dove Medical Press Limited

Buscando em bases de dados remotas. Favor aguardar.